Feds Reschedule CBD Drugs But There's A Catch

The rescheduling does not apply to all CBD drugs. Following the approval of CBD-based epilepsy drug Epidolex by the Food and Drug Administration (FDA), the US federal government has decided that, going forward, it will reschedule all CBD medications that the FDA approves. As of Friday, the rescheduling order has been published to the official… Continue reading Feds Reschedule CBD Drugs But There's A Catch

Exit mobile version